{{Drugbox
| IUPAC_name = (8''S'',13''S'',14''S'',17''S'')-17-Acetyl-13,17-dimethyl-1,2,6,7,8,11,12,14,15,16-decahydrocyclopenta[a]phenanthren-3-one
| image = Demegestone.svg
| width = 200
| alt = Skeletal formula of demegestone
| image2 = Demegestone 3D ball.png
| width2 = 200
| alt2 = Ball-and-stick model of the demegestone molecule
| CAS_number = 10116-22-0
| UNII_Ref = {{fdacite|correct|FDA}}
| UNII = 6E89AM91SZ
| ATC_prefix = G03
| ATC_suffix = DB05
| PubChem = 93057
| DrugBank = 
| ChemSpiderID = 84009
| KEGG = D07223
| C=21 | H=28 | O=2
| molecular_weight  = 312.446 g/mol
| smiles = CC(=O)[C@]1(CC[C@@H]2[C@@]1(CCC3=C4CCC(=O)C=C4CC[C@@H]23)C)C
| synonyms = R-2453, RU-2453; 17α-Methyl-19-norpregna-4,9-diene-3,20-dione
| StdInChI = 1S/C21H28O2/c1-13(22)20(2)11-9-19-18-6-4-14-12-15(23)5-7-16(14)17(18)8-10-21(19,20)3/h12,18-19H,4-11H2,1-3H3/t18-,19+,20-,21+/m1/s1
| StdInChIKey = JWAHBTQSSMYISL-MHTWAQMVSA-N
| bioavailability = 
| protein_bound = 
| metabolism = 
| elimination_half-life = 
| excretion = 
| pregnancy_AU =  <!-- A / B1 / B2 / B3 / C / D / X -->
| pregnancy_US =  <!-- A / B / C / D / X -->
| pregnancy_category =  
| legal_AU =  <!-- S2, S3, S4, S5, S6, S7, S8, S9 or Unscheduled-->
| legal_CA =  <!-- Schedule I, II, III, IV, V, VI, VII, VIII -->
| legal_UK =  <!-- GSL, P, POM, CD, or Class A, B, C -->
| legal_US =  <!-- OTC / Rx-only / Schedule I, II, III, IV, V -->
| legal_status = 
| routes_of_administration = 
}}

'''Demegestone''' ([[International Nonproprietary Name|INN]]) (brand name '''Lutionex'''), also known as '''17α-methyl-Δ<sup>9</sup>-19-norprogesterone''' or '''17α-methyl-19-norpregna-4,9-diene-3,20-dione''',<ref name="Elks2014" /> is a [[steroid]]al [[progestin]] of the [[19-norprogesterone]] group which was introduced by [[Roussel Uclaf|Roussel]] in [[France]] in 1974.<ref name="Elks2014">{{cite book|author=J. Elks|title=The Dictionary of Drugs: Chemical Data: Chemical Data, Structures and Bibliographies|url=https://books.google.com/books?id=0vXTBwAAQBAJ&pg=PA356|date=14 November 2014|publisher=Springer|isbn=978-1-4757-2085-3|pages=356–}}</ref><ref name="Publishing2013">{{cite book|author=William Andrew Publishing|title=Pharmaceutical Manufacturing Encyclopedia, 3rd Edition|url=https://books.google.com/books?id=_J2ti4EkYpkC&pg=PA1215|date=22 October 2013|publisher=Elsevier|isbn=978-0-8155-1856-3|pages=1215–}}</ref> Like other 19-norprogesterone derivatives, it has relatively high [[affinity (pharmacology)|affinity]] for the [[progesterone receptor]] and shows little or no activity at other [[steroid hormone receptor]]s.<ref name="Milsom2006">{{cite book|author=Ian Milsom|title=Contraception and Family Planning|url=https://books.google.com/books?id=HUbDJ98p0vwC&pg=PA102|year=2006|publisher=Elsevier Health Sciences|isbn=0-444-51828-2|pages=102–}}</ref>

==See also==
* [[Gestonorone caproate]]
* [[Medrogestone]]
* [[Nomegestrol acetate]]
* [[Promegestone]]
* [[Segesterone acetate]]
* [[Trimegestone]]

==References==
{{Reflist|2}}


{{Progestogens and antiprogestogens}}
{{Progesterone receptor modulators}}

[[Category:Diketones]]
[[Category:Norpregnanes]]
[[Category:Progestogens]]


{{steroid-stub}}
{{genito-urinary-drug-stub}}